Tae Heum Jeong
2017
In 2017, Tae Heum Jeong earned a total compensation of $435.3K as Former Chief Financial Officer at Rexahn Pharmaceuticals, a 11% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $73,500 |
|---|---|
| Option Awards | $34,658 |
| Salary | $300,000 |
| Stock Awards | $11,592 |
| Other | $15,557 |
| Total | $435,307 |
Jeong received $300K in salary, accounting for 69% of the total pay in 2017.
Jeong also received $73.5K in non-equity incentive plan, $34.7K in option awards, $11.6K in stock awards and $15.6K in other compensation.
Rankings
In 2017, Tae Heum Jeong's compensation ranked 12,343rd out of 14,666 executives tracked by ExecPay. In other words, Jeong earned more than 15.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,343 out of 14,666 | 16th |
Division Manufacturing | 4,858 out of 5,772 | 16th |
Major group Chemicals And Allied Products | 1,780 out of 2,075 | 14th |
Industry group Drugs | 1,478 out of 1,731 | 15th |
Industry Pharmaceutical Preparations | 1,145 out of 1,333 | 14th |
Source: SEC filing on April 23, 2018.
Jeong's colleagues
We found three more compensation records of executives who worked with Tae Heum Jeong at Rexahn Pharmaceuticals in 2017.